Class 3 Medicines Recall: Bayer Plc, Various Products, EL(26)A/12

Primary tabs

Bayer Plc is recalling all stock of the products listed in this notification as a precautionary measure due to the identification of an impurity above the acceptable limit. The recall is at pharmacy and wholesaler level.

DMRC Number: DMRC- 38673150

Company name:Bayer Plc

Product description: Gastrografin gastroenteral solution

PL: 00010/0537

Active ingredients: meglumine amidotrizoate and sodium amidotrizoate

SNOMED code: 9757711000001100

Details of the affected batch:

Batch No.Expiry DatePack SizeFirst Distributed
MA04HM902/202810x100ml01/05/2024
MA04JKA03/202810x100ml31/05/2024
MA04KFC04/202810x100ml30/07/2024
MA04KJ904/202810x100ml01/08/2024
MA04M6007/202810x100ml23/09/2024
MA04MLL08/202810x100ml04/11/2024
MA04MM909/202810x100ml15/12/2024
MA04MN909/202810x100ml19/01/2025
MA04NDU10/202810x100ml13/02/2025
MA04NNB11/202810x100ml06/03/2025
MA04PJL12/202810x100ml15/04/2025
MA04PLZ12/202810x100ml29/05/2025
MA04PMV01/202910x100ml11/07/2025
MA04RL202/202910x100ml14/08/2025
MA04RL302/202910x100ml15/09/2025
MA04S6C02/202910x100ml30/10/2025
MA04S6B02/202910x100ml03/10/2025
MA04S6T02/202910x100ml02/12/2025
MA04XJ807/202910x100ml09/01/2026

Product description: Urografin 150 Infusion

PL: 00010/0568

Active ingredients: meglumine amidotrizoate and sodium amidotrizoate

SNOMED code: 8058511000001109 (250 ml 8058911000001102 (500 ml)

Details of the affected batch:

Batch No.Expiry DatePack SizeFirst Distributed
MA044UD03/20261x250ml09/02/2023
MA04A5803/20261x250ml27/06/2023
MA04BVD07/20261x250ml09/11/2023
MA04BVE07/20261x250ml23/01/2024
MA04HS802/20291x250ml04/06/2024
MA04L2M02/20291x250ml18/07/2024
MA04LTC05/20291x250ml27/08/2024
MA04NAL07/20291x250ml11/12/2024
MA04MK608/20291x250ml19/11/2024
MA04SJ309/20291x250ml03/07/2025
MA04NB810/20291x250ml23/04/2025
MA04UXS10/20291x250ml15/10/2025
MA04VPT05/20301x250ml12/01/2026
MA042CN05/20261x500ml24/06/2022
MA044U405/20261x500ml01/11/2022
MA048LU05/20261x500ml09/03/2023
MA04BV005/20261x500ml26/07/2023
MA04FRU05/20261x500ml12/03/2024
MA044U907/20261x500ml02/03/2023
MA04TLV03/20301x500ml29/07/2025

Product description: Urografin 150 Injection

PL: 00010/0569

Active ingredients: meglumine amidotrizoate and sodium amidotrizoate

SNOMED code: 8057711000001100 (10 ml) 8058111000001100 (20 ml)

Details of the affected batch:

Batch No.Expiry DatePack SizeFirst Distributed
MA042JA06/202610x10ml28/07/2022
MA046UT06/202610x10ml19/12/2022
MA0496X06/202610x10ml29/03/2023
MA04AP006/202610x10ml08/08/2023
MA04BX706/202610x10ml27/10/2023
MA04FHP06/202610x10ml13/06/2024
MA04KJB06/202610x10ml15/08/2024
MA04L4506/202610x10ml15/09/2024
MA04S8T02/203010x10ml17/06/2025
MA043T709/202610x20ml13/09/2022
MA046TS09/202610x20ml20/02/2023
MA0497C09/202610x20ml21/03/2023
MA04R4R09/202910x20ml25/04/2025

Background information: 

Bayer Plc is recalling all stock of the above products as a precautionary measure due to the identification of an impurity above the acceptable limit. The recall is at pharmacy and wholesaler level.

Advice to Healthcare Professionals: 

Stop supplying the above batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.

Advice for Healthcare Professionals to Provide to Patients: 

No action is required by patients. The medication is administered by healthcare professionals for use during radiological examinations. The recall is at the wholesaler and pharmacy level.

The products are being recalled out of an abundance of caution, no reports of patient harm have been received from patients relating to this defect.

Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

Company contacts for further information: 

For all medical information enquiries and information on this product, please email medical.information@bayer.co.uk, or telephone 0118 206 3116.

For stock control enquiries please email orders-uk@bayer.com, or telephone 0118 206 3131.

To access the full recall/alert: 

Class 3 Medicines Recall: Bayer Plc, Various Products, EL(26)A/12